Search for more clinical trials
Use of Hair to Diagnose Breast Cancer
Conditions
Breast Cancer
Conditions: official terms
Breast Neoplasms
Conditions: Keywords
x-ray diffraction, hair, breast cancer, synchrotron
Study Type
Interventional
Study Phase
Phase 2
Study Design
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Diagnostic
Intervention
Name: Cutting scalp hair
Type: Procedure
Overall Status
Recruiting
Summary
This study aims to perform x-ray diffraction analysis of blinded hair samples from women with a documented health status, to validate the previous findings of James et al who described that x-ray diffraction patterns of human hair can distinguish samples from healthy subjects from those of diseased subjects, specifically those suffering from breast cancer.
The primary hypothesis is that x-ray diffraction of hair can be used to distinguish hair from patients with confirmed breast cancer from subjects without detectable breast cancer.
The primary hypothesis is that x-ray diffraction of hair can be used to distinguish hair from patients with confirmed breast cancer from subjects without detectable breast cancer.
Criteria for eligibility
Healthy Volunteers:
Maximum Age: N/A
Minimum Age: 20 Years
Gender: Female
Criteria: Inclusion Criteria:
- Adult women (aged >20) who are undergoing mammography, and
- Who are willing and able to provide informed consent; and
- Who have usable scalp hair
Exclusion Criteria:
- Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN: cervical intra-epithelial neoplasia) within 5 years.
- Adult women (aged >20) who are undergoing mammography, and
- Who are willing and able to provide informed consent; and
- Who have usable scalp hair
Exclusion Criteria:
- Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN: cervical intra-epithelial neoplasia) within 5 years.
Location
St George Private Hospital
Sydney, New South Wales, Australia
Status: Recruiting
Start Date
October 2006
Sponsors
Fermiscan Ltd
Source
Fermiscan Ltd
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page